Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

NASDAQ:AWH

Aspira Women's Health Inc. Common Stock

Last Close

0.86

08/11 21:00

Market Cap

13.81M

Beta: 2.93

Volume Today

48.64K

Avg: 243.20K

PE Ratio

−2.56

PFCF: −2.48

locale

market

industry

website

ipo date

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics